Published in Medical Letter on the CDC and FDA, October 31st, 2004
"Through this surveillance study we seek to corroborate findings of the landmark SAPPHIRE study, the only randomized clinical trial conducted to validate the potential of carotid artery stent placement in high surgical-risk patients," said Subbarao Myla, MD, medical director, cardiovascular research and vascular interventions, Hoag...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA